CVE-2002-0236

CVE-2002-0236 is a high-severity vulnerability in Lucent Vitalanalysis with a CVSS 2.0 base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

Lucent VitalSuite 8.0 through 8.2, including VitalNet, VitalEvent, and VitalHelp/VitalAnalysis, allows remote attackers to bypass authentication via a direct HTTP request to the VsSetCookie.exe program, which returns a valid cookie for the desired user.

Frequently asked questions

What is CVE-2002-0236?
Lucent VitalSuite 8.0 through 8.2, including VitalNet, VitalEvent, and VitalHelp/VitalAnalysis, allows remote attackers to bypass authentication via a direct HTTP request to the VsSetCookie.exe program, which returns a valid cookie for the desired user.
How severe is CVE-2002-0236?
CVE-2002-0236 has a CVSS 2.0 base score of 7.5, rated high severity.
Is CVE-2002-0236 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 7% (94th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2002-0236?
CVE-2002-0236 primarily affects Lucent Vitalanalysis. In total, 15 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2002-0236?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2002-0236 published?
CVE-2002-0236 was published on 2002-05-29 and last updated on 2026-06-16.

References

Affected products (15)